P523: THE COMPARISON OF VFLAI, FLAI AND 3 + 7 REGIMENS BY MULTILEVEL PROPENSITY SCORE WEIGHTING HIGHLIGHTS THE BENEFIT OF THE ADDITION OF VENETOCLAX IN NO LOW‐RISK AML TREATED IN GIMEMA TRIALS AND REAL WORLD

Saved in:
Bibliographic Details
Published inHemaSphere Vol. 7; no. S3; pp. e0034216 - n/a
Main Authors Piciocchi, Alfonso, Marconi, Giovanni, Cipriani, Marta, Messina, Monica, Guolo, Fabio, Minetto, Paola, Paoloni, Francesca, Cotugno, Francesca, DI Donato, Laura, Simonetti, Giorgia, Palmieri, Raffaele, Buccisano, Francesco, Fazi, Paola, Vignetti, Marco, M. Lemoni, Roberto, Venditti, Adriano, Martinelli, Giovanni
Format Journal Article
LanguageEnglish
Published Philadelphia, PA Lippincott Williams & Wilkins 08.08.2023
Wiley
Online AccessGet full text

Cover

More Information
ISSN:2572-9241
2572-9241
DOI:10.1097/01.HS9.0000969000.00342.16